OPFOLDA 65 mg, hard capsule 24 capsules
Active ingredients: Miglustat
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule24 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OPFOLDA 65 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- 1 bouteille polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 24 gélules
- Marketing authorisation holder
- AMICUS THERAPEUTICS EUROPE (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 9 Nov 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61479921CIP75509631CIP133400955096313Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MIGLUSTATgélule | 65 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.